PATIENT EXPECTATIONS OF TREATMENT GOALS AND GOAL-SETTING PRACTICES IN RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM by Taylor, P, Strand, V, Sensky, T, Harta, N, Fleming, S

Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies by Bangert E, Wakani L, Merchant M, Strand V, Touma Z

Get full text

Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certoli... by Hazes, J, Taylor, P, Strand, V, Purcaru, O, Coteur, G, Mease, P

Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis... by Strand, V, Sebba, A, Scardo, S, Quebe, A, Zaremba-Pechmann, L, Taylor, P, Sholter, D

Rapid and concurrent improvements in patient-reported outcomes of rheumatoid arthritis with baricitinib in RA-BEAM by Strand, V, Sebba, A, Jia, B, Birt, J, Quebe, A, Zhang, H, Taylor, PC

Classification and outcome measures for psoriatic arthritis by Leung, Y, Ogdie, A, Orbai, A, Tillett, W, Coates, L, Strand, V, Mease, P, Gladman, D

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies by Tillett, W, Orbai, A, Ogdie, A, Leung, Y, Strand, V, Gladman, D, Mease, P, Coates, L

Measurement properties of the minimal disease activity criteria for psoriatic arthritis by Coates, L, Strand, V, Wilson, H, Revicki, D, Stolshek, B, Samad, A, Chung, J, Gladman, D, Mease, P

The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial by Strand, V, Kaeley, GS, Bergman, MJ, Gladman, DD, Coates, LC, Sherif, B, Hur, P, Parikh, B, Gilloteau, I, Mease, PJ

A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite mea... by Mease, PJ, Gladman, DD, Collier, D, Ritchlin, CT, Helliwell, P, Coates, LC, Strand, V, Liu, L, Kricorian, G, Chung, J

Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: a randomised, crossover, agreement study by Uhrenholt, L, Høstgaard, S, Pedersen, JF, Christensen, R, Dreyer, L, Leffers, HCB, Taylor, PC, Strand, V, Jacobsen, S, Voss, A, Gregersen, JW, Kristensen, S

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial by Helliwell, PS, Mease, PJ, Kavanaugh, A, Coates, LC, Ogdie, A, Deodhar, A, Strand, V, Kricorian, G, Liu, L, Collier, D, Gladman, DD

Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: results from a randomized phase 2 trial by Strand, V, Gossec, L, Coates, LC, Ogdie, A, Choi, J, Becker, B, Zhuo, J, Lehman, T, Nowak, M, Elegbe, A, Mease, PJ, Deodhar, A

Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis by Leung, YY, Orbai, A-M, Ogdie, A, Hojgaard, P, Holland, R, Goel, N, Chau, J, Coates, LC, Strand, V, Gladman, DD, Mease, P, Christensen, R, Tillett, W

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 annual meeting: report and plan for completing the core outcome measurement set by Leung, Y, Orbai, A, Ogdie, A, Coates, L, De Wit, M, Callis Duffin, K, Eder, L, Gladman, D, Goel, N, Mease, P, Strand, V, Fitzgerald, O, Tillett, W

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the... by Coates, L, Gladman, D, Nash, P, Fitzgerald, O, Kavanaugh, A, Kvien, T, Gossec, L, Strand, V, Rasouliyan, L, Pricop, L, Ding, K, Jugl, S, Gaillez, C, Future 2 Study Group

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis by Coates, L, Merola, JF, Mease, PJ, Ogdie, A, Gladman, DD, Strand, V, van Mens, L J.J., Liu, L, Yen, PK, Collier, DH, Kricorian, G, Chung, JB, Helliwell, PS

Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study by Skougaard, M, Jørgensen, TS, Jensen, MJ, Ballegaard, C, Guldberg-Møller, J, Egeberg, A, Christensen, R, Benzin, P, Stisen, ZR, Merola, JF, Coates, LC, Strand, V, Mease, P, Kristensen, LE

Test-retest reliability for HAQ-DI and SF-36 PF for the measurement of physical function in psoriatic arthritis by Leung, YY, Tillett, W, Hojgaard, P, Orbai, A-M, Holland, R, Mathew, AJ, Goel, N, Chau, J, Lindsay, C, Ogdie, A, Coates, LC, Christensen, R, Mease, P, Strand, V, Gladman, DD

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review by Leung, Y-Y, Holland, R, Mathew, AJ, Lindsay, C, Goel, N, Ogdie, A, Orbai, A-M, Hojgaard, P, Chau, J, Coates, LC, Strand, V, Gladman, DD, Christensen, R, Tillett, W, Mease, P